SIGNIFICANCE OF A PARTIAL OR SLOW RESPONSE TO FRONT-LINE CHEMOTHERAPY IN THE MANAGEMENT OF INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA - A LITERATURE-REVIEW

被引：43
|
作者：
HAQ, R
SAWKA, CA
FRANSSEN, E
BERINSTEIN, NL
机构：
[1] TORONTO BAYVIEW REG CANC CTR,DEPT MED,TORONTO M4N 3M5,ON,CANADA
[2] TORONTO BAYVIEW REG CANC CTR,DEPT CLIN TRIALS & EPIDEMIOL,TORONTO M4N 3M5,ON,CANADA
[3] TORONTO BAYVIEW REG CANC CTR,DEPT IMMUNOL,TORONTO M4N 3M5,ON,CANADA
[4] SUNNYBROOK HLTH SCI CTR,TORONTO M4N 3M5,ON,CANADA
[5] UNIV TORONTO,TORONTO,ON,CANADA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 05期
关键词：
D O I：
10.1200/JCO.1994.12.5.1074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1074 / 1084
页数：11
相关论文
共 50 条
  • [41] CASES OF THE MONTH - HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMA OF THE LIVER
    SOUHAYL, A
    LANDMANPARKER, J
    LEPOINTE, HD
    ARCHIVES FRANCAISES DE PEDIATRIE, 1993, 50 (09): : 797 - 799
  • [42] PROGRESSIVE LOSS OF VISION IN PATIENTS WITH HIGH-GRADE NON-HODGKINS-LYMPHOMA
    HOLTE, H
    SAETER, G
    DAHL, IMS
    ABRAHAMSEN, AF
    CANCER, 1987, 60 (10) : 2521 - 2523
  • [43] A COMPARATIVE-STUDY OF CHOP VERSUS MEVP (MITOXANTRONE, ETOPOSIDE, VINDESINE, PREDNISOLONE) THERAPY FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - A PROSPECTIVE RANDOMIZED STUDY
    TAKAGI, T
    SAMPI, K
    SAWADA, U
    SAKAI, C
    OGURO, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1993, 57 (01) : 67 - 71
  • [44] HODGKINS-DISEASE, FOLLICULAR NON-HODGKINS-LYMPHOMA AND A HIGH-GRADE B-CELL NON-HODGKINS-LYMPHOMA IN THE SAME PATIENT
    GIBBS, SJ
    TOBIAS, JS
    LEUKEMIA & LYMPHOMA, 1995, 18 (1-2) : 185 - 187
  • [45] INTERMEDIATE AND HIGH-GRADE GASTRIC NON-HODGKINS-LYMPHOMA - A PROSPECTIVE-STUDY OF NONSURGICAL TREATMENT WITH PRIMARY CHEMOTHERAPY, WITH OR WITHOUT RADIOTHERAPY
    HAIM, N
    LEVIOV, M
    BENARIEH, Y
    EPELBAUM, R
    FREIDIN, N
    RESHEF, R
    BENSHAHAR, M
    LEUKEMIA & LYMPHOMA, 1995, 17 (3-4) : 321 - 326
  • [46] CAVBP DEP ALTERNATING CHEMOTHERAPY FOR THE TREATMENT OF INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - FINAL RESULTS OF A PILOT-STUDY
    PALMIERI, G
    CAPONIGRO, F
    IAFFAIOLI, RV
    CONTEGIACOMO, A
    MONTESARCHIO, V
    LAURIA, R
    CALDEROPOLI, R
    PAGLIARULO, C
    GRIDELLI, C
    BIANCO, AR
    HEMATOLOGICAL ONCOLOGY, 1990, 8 (06) : 313 - 322
  • [47] ALTERNATING CHEMOTHERAPY REGIMEN (P-VABEC) FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA OF THE MIDDLE-AGED AND ELDERLY
    CARACCIOLO, F
    PETRINI, M
    CAPOCHIANI, E
    PAPINESCHI, F
    CARULLI, G
    GRASSI, B
    HEMATOLOGICAL ONCOLOGY, 1994, 12 (04) : 185 - 192
  • [48] SOUTHWEST ONCOLOGY GROUP CLINICAL-TRIALS FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS LYMPHOMAS
    MILLER, TP
    DANA, BW
    WEICK, JK
    JONES, SE
    COLTMAN, CA
    DAHLBERG, S
    FISHER, RI
    SEMINARS IN HEMATOLOGY, 1988, 25 (02) : 17 - 22
  • [49] ACUTE TUMOR LYSIS SYNDROME IN PATIENTS WITH HIGH-GRADE NON-HODGKINS-LYMPHOMA
    HANDE, KR
    GARROW, GC
    AMERICAN JOURNAL OF MEDICINE, 1993, 94 (02): : 133 - 139
  • [50] INACTIVATION OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE IN A HUMAN HIGH-GRADE NON-HODGKINS-LYMPHOMA CELL-LINE
    WEIDE, R
    DOWDING, C
    SUCAI, B
    BUNGEY, J
    CHASE, A
    GOLDMAN, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (04) : 500 - 505
12345